tbuckley/cabot-search huggingface dataset:
Integration of Deep Learning in Baseline PET/CT and Multi-Omics Data for Prognostic Modeling in Diffuse Large B-Cell Lymphoma: The Clinicalpet Lymphplex Model
Authors: Yue Wang, Xue Wang, Xinyun Huang, Ying Qian, Rongji Mu, Qing Shi, Di Fu, Hongmei Yi, Bin-Shen Ou-Yang, Zhuo Han Li, Shu Cheng, Wang Li, Ning Wen, Pengpeng Xu, Wei Li Zhao
Journal: Blood (2024)
Reni-Cel, an Investigational AsCas12a Gene-Edited Cell Medicine, Led to Successful Engraftment, Increased Hemoglobin, and Reduced Transfusion Dependence in Patients with Transfusion-Dependent Beta-Thalassemia Treated in the Edithal Trial
Authors: Haydar Frangoul, Rabi Hanna, Mark C. Walters, Kai-Hsin Chang, Michael Jaskolka, Keunpyo Kim, Baisong Mei, Olubunmi Afonja, Alexis Thompson
Journal: Blood (2024)
Tolerability of Bispecific Antibodies in Relapse/Refractory Multiple Myeloma (RRMM) Patients with Severe Renal Insufficiency: Case Series
Authors: Yvonne A. Efebera, Basem M. William, Rebecca Tokarski, Julie Catanzaro, Rebecca Mensah, Gary Scott, Cassandra Gillespie, Emilee Young, Melissa Caulfield, Quinn Verfurth, Hermon Ghebremedhin, Anna Griffin, Jessie Kichigin, Rebecca Smiley, Audra Phillips, Dan Feinberg, Megan Thompson, Sara Braskett, Allyson Renner, Jennifer Minner, Alexandria Lipstraw, Rose Bope, Mitchell Brown, Julia Burns, Isha Bangura, Rhonda Hubbard, Bridgitte Brady, Stephanie Minor, Prashant Trikha, Greeballa Magzoub, Melissa Royero, Evan James
Journal: Blood (2024)
Dysregulation of Transcription Machinery Drives the Acquisition of BTK Inhibitor and Venetoclax Treatment Resistance in Mantle Cell Lymphoma
Authors: Jing Gao, Kevin Qiu, Kallesh Danappa Jayappa, Qing Yin, Michelle Wang, Allen Hu, Danielle C Llaneza, Loryn L Blackburn, Jeffrey W Craig, Bijal D Shah, Craig A. Portell, Michael E Williams, Chongzhi Zang, Jianguo Tao
Journal: Blood (2024)
Mitoxantrone Hydrochloride Liposome Combined with Polatuzumab Vedotin and Dexamethasone (MPD) Is Highly Effective and Well Tolerated As Bridging Therapy before Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Authors: Xin-di Liu, Jia Cong, Lei Yang, Jing Yang, Liang Wang
Journal: Blood (2024)
High-Risk TP53-Mutated Acute Myeloid Leukemia in Puerto Rico: Elevated Variant Allele Frequency and Clinical Implications
Authors: Ian Crespo Orta, William Marrero Leon, Hector R Cintron-Colon, Dominic Sanchez Paredes, Cristian I. Rodriguez-Arocho, William Caceres, Alexis M. Cruz-Chacon
Journal: Blood (2024)
Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup Analysis
Authors: Gang An, Zhuogang Liu, Jie Jin, Zhen Cai, Wei Li, Zhongjun Xia, Xinan Cen, Yu Hu, Jian-Qing Mi, Hongmei Jing, Rong Zhan, Xiaoyan Qu, Xin Du, Dan Gao, Liang Zhao, Lugui Qiu
Journal: Blood (2024)
Engineering FVIII Protein for Enhancing Expression and Secretion Profile to Achieve Normal Level of FVIII in Plasma Utilizing Noninvasive Transcutaneous Ultrasound Mediated Gene Delivery
Authors: Ivan Krivega, Margarita Krivega, Julia Poniatowski, David Kim, Elizabeth Del Greco, Surabhi Rao, Victor Foster, Bert Frederich, Glenda Arauz, Celia Ortiz, Oliver Chen, Tanaya Ghosh, Dhruv Bole, Katelyn N Benthall, Anagha Rao, David Satyadi, Zoya Gulzman-Poltorak, Steve Feinstein, Kenneth Greenberg
Journal: Blood (2024)
HDAC Inhibition Rejuvenates Antitumor Immunity in Acute Myeloid Leukemia Via CD9 Transcriptional Reactivation
Authors: Yaqun Xu, Kathy Yuen Yee Chan, Qiwei SUN, Yixuan Wu, Siu Ping Fok, Chi Kong Li, Kam Tong Leung
Journal: Blood (2024)
Genomic Studies in Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders Show Alterations That Differ from Aggressive CD30-Positive T-Cell Lymphomas
Authors: Joo Y. Song, Weiwei Zhang, Michi M. Shinohara, Kord Honda, Christiane Querfeld, Julia Davidson, Krystie Chew, Lu Chen, Alexandra Hristov, Jasmine Zain, Anamarija M. Perry, Wing Chung Chan, Farah R Abdulla
Journal: Blood (2024)
New Diagnostic Technology for the Isolation and Analysis of Live Myeloma Cell from the Blood of Multiple Myeloma Patients
Authors: Hoin Kang, Jihyun Lee, Soee Kim, Ju Bi Lee, Hyo Yong Kim, Min Hyung Kim, Hyeonji Cho, SangEun Yoon, Kihyun Kim, Jungwon Kim
Journal: Blood (2024)
Utility of Baseline PET/CT As Surrogate of Molecular Features in Mantle Cell Lymphoma
Authors: Amanda Isabel Perez, Cristina Lopez, Sonia Rodriguez, Guillem Clot, Ferran Nadeu, Anna Montaner, Carlos Jimenez-Vicente, Julio Delgado, Laura Magnano, Juan Gonzalo Correa, Pablo Mozas, Andrea Rivero, Anna Gaya, Marta Gómez, Alfredo Rivas-Delgado, Ana Muntañola, Sebastian Casanueva-Eliceiry, Aida Niñerola-Baizan, Gerard Frigola, Elías Campo, Armando Lopez-Guillermo, Xavier Setoain, Silvia Bea, Eva Gine
Journal: Blood (2024)
Artificial Intelligence Models for Risk Stratification and Prognosis in AML-NOS
Authors: Álvaro López-Caro, Ana Mendoza, Miguel Gómez-Álvarez, Marta Hidalgo Soto, Adriana Oñós Clausell, Sandra Rodríguez San Antolín, David Bermejo-Peláez, Nuria Díez Navarro, David Brau Queralt, Maria Postigo Camps, Rafael Colmenares Gil, Maria Jesus Ledesma-Carbayo, María Linares, Julia Montoro, Celina Benavente Cuesta, Miguel Luengo-Oroz, Joaquin Martínez-López
Journal: Blood (2024)
Specific Nucleotide Modifications Induce Neopeptides with High Major Histocompatibility Complex Binding in Myeloid Malignancies
Authors: Ali Firozvi, Alexandra Thalberg, Hafsa Bhatty, Munther Hammad, Lacey Scott Williams, Olivia Wilkins, Sarah Elizabeth Mudra, Rachel Zemel, Garrett Diltz, Anne S. Renteria, Gustavo A. Rivero
Journal: Blood (2024)
Chidamide Combination with Chemotherapy As the First-Line Treatment for T-Cell Acute Lymphoblastic Leukemia: A Single-Center Retrospective Study
Authors: Mengyao Li, Zi-Yuan Nie, Jinhai Ren, Xiaohong Zhang, Jinao Li, Ying Zhan, Xiaolei Zhang, Xiaoling Guo
Journal: Blood (2024)
Racial Disparities in in-Hospital Outcomes of Venous Thromboembolic Events in Patients with Diffuse Large B-Cell Lymphoma
Authors: Dosbai Saparov, Henry Becerra, Mustafa Wasifuddin, Ifeanyi Nnamdi Uche, Shakirat Gold-Olufadi, Azamat Abdyraimov, Narek Hakobyan, Hesham Ali Abowali, Akriti Pokhrel, Ruchi Yadav, Rukhsana Aslam, Neharika Shrestha, Aleksandr Markov, Jen Chin Wang
Journal: Blood (2024)
Preliminary Efficacy and Safety of Bruton Tyrosine Kinase (BTK) Inhibitor HZ-a-018 in Adult Patients with Relapsed and/or Refractory (R/R) Central Nervous System Lymphoma or Treatment-Naïve (TN) Central Nervous System Lymphoma, Results from the Phase Ib Combination Part of HZ-a-018-102 Study
Authors: Wenbin Li, Zhuang Kang, Feng Chen, Shenglan Li, Xi Chen, Xianggui Yuan, Haiyan Yang, Wenbin Qian, Miao Hu, Yanping Zhang, Xinglu Zhou
Journal: Blood (2024)
MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated a Favorable Safety and Potent Antitumor Activity in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma: Preliminary Results from a Phase Ⅰ, Dose-Escalation Trial
Authors: Yuqin Song, Haiyan Yang, Youchao Jia, Lixia Sheng, Lijuan Deng, Xi Chen, Yongjing Tang, Xifang Liu, Sijun Liu, Min Wei, Feng Li
Journal: Blood (2024)
Unfractionated Heparin Resourced from Bovine, Ovine, and Porcine Origin Is Bioequivalent
Authors: Nikunj Thakkar, Kannan Meganathan, Yash Gupta, Gia Kapur, Jeanine M. Walenga, Debra Hoppensteadt, Walter Jeske, Pradeep Aggarwal, Jawed Fareed
Journal: Blood (2024)
Association of PD-L1 Expression with Clinico-Pathological Factors and Treatment Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) from a Tertiary Care Cancer Center in Southern India
Authors: Pradnya Modak, Swarna Shivakumar, Sabhari Priya, Muthulingesh Kumar, Varsha Bhandarkar, Jahnavi Peddireddy, Kalyani Premchandra, Narendhar Gokulanathan, Arya S. Nath, Neha Surendra Gawarle, Govindarajan Mallarajapatna, Anoop Nagraj P, Channappa Nagraj Patil, Neema Bhat, Poonam Maurya, Vishwanath Sathyanarayanan
Journal: Blood (2024)
Venetoclax As a Combination Partner with NAMPT Inhibitor Rpt-1G for T-ALL
Authors: John R. Sanchez, Daisy Y. Diaz Rohena, Charmelle D. Williams, Valerio Ciaurro, Min Wu, Francis Roushar, Dennise A. De Jesús-Díaz, Gregory Crimmins, Vinay Puduvalli, Francisco Vega, Palaniraja Thandapani, Deepa Sampath
Journal: Blood (2024)
Barriers to First-Line Therapy in Plasmablastic Lymphoma: A Retrospective Study in a Middle-Income Country
Authors: Irma Karen Pellon Tellez, Luis Felipe Rubalcava, Omar Eduardo Fernandez Vargas, Gilda Coralia Cetina Castro, Mistral Castellanos Mares, Andres Yesid Yesid Bonilla Salcedo, Gabriela N. Cesarman-Maus, Brenda Lizeth Acosta Maldonado
Journal: Blood (2024)
Methods to Assess the Impact of Combined Pharmacologic and Transfusion Therapies on Red Cell Deformability
Authors: Abhinav K Pasupuleti, Akshay A Patwardhan, Ashwin P. Patel, Solomon Oshabaheebwa, Christopher A. Delianides, Zoe Sekyonda, Erica N Evans, Lindsey Abel, Michael A. Suster, Pedram Mohseni, Umut Gurkan, Vivien Sheehan
Journal: Blood (2024)
Glofitamab in Combination with R-ICE Chemoimmunotherapy or as Monotherapy in Children and Adolescents with Relapsed/Refractory B-cell non-Hodgkin Lymphoma: Initial Safety and Efficacy Results from the Ongoing iMATRIX-GLO Study
Authors: Véronique Minard-Colin, Maitane Andión Catalán, Luciana Vinti, Hyoung Jin Kang, Nora Rahmani, Katia Gamel, Jade Wulff, Saibah Chohan, Raluca Negricea, Beate Wulff, Birgit Burkhardt
Journal: Blood (2024)
Detection of MRD Using <i>IGH</i> Assay By NGS after Second Cycle of Chemotherapy in Adult B-Lymphoblastic Leukemia Predicts Poor Clinical Outcomes: Results from a Multicenter Study
Authors: Chantana Polprasert, Chantiya Chanswangphuwana, Kitsada Wudhikarn, Wasithep Limvorapitak, Thanawat Rattanathammethee, Thanakrit Piyajaroenkij, Sirorat Kobbuaklee, Adisak Tantiworawit
Journal: Blood (2024)
Human Gene Therapy Optimized for the Platelet Bleeding Disorder Glanzmann Thrombasthenia
Authors: Juan Fang, Matthew Hogenauer, Aoife M. Roche, Sevasti B. Koukouritaki, Lily M. Du, Huiqing Xu, John Everett, Frederic D. Bushman, Myriam Armant, Peiman Hematti, David A. Wilcox
Journal: Blood (2024)
The Prognostic Significance of Serum β2- Microglobulin Levels (sβ2m) in Diffuse Large B-Cell Lymphoma (DLBCL)
Authors: Maria Panagiota Arapaki, Evgenia Verrou, Sotirios G. Papageorgiou, Amalia Anastasopoulou, Sotirios Sachanas, Alexia Piperidou, Theodora Triantafyllou, Pinelopi Vryttia, Maria Anastasia Ioakeim, Athanasios Liaskas, Christina H. Kalpadakis, Marina Siakantaris, Maria Dimou, Marie-Christine Kyrtsonis, Gerasimos Tsourouflis, Helen A Papadaki, Kostas Konstantopoulos, Vassiliki Pappa, Gerassimos Pangalis, Panayiotis Panayiotidis, Eirini Katodritou, Maria Angelopoulou, Theodoros P. Vassilakopoulos
Journal: Blood (2024)
Efficacy of Combinations of Targeted Agents Against Dependencies in Mecom Rearranged AML Identified By Unbiased Chemical and CRISPR Screens
Authors: Christine Birdwell, Warren C. Fiskus, Christopher Peter Mill, Surbhi Sharma, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Koji Sasaki, John A. Davis, Kaberi Das, Hanxi Hou, Michele Ceribelli, Kapil N. Bhalla
Journal: Blood (2024)
Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma
Authors: Rafael Martin De Jesus Pichardo Rodriguez, Brady Beltran, Myrna Candelaria, Maria Alejandra Torres Viera, Ana Florencia Ramirez, Henry Idrobo, Ana Carolina Oliver, Guilherme Fleury Perini, Efreen Montano Figueroa, Laura Korin, Lorena Fiad, German R. Stemmelin, Fernando Perez-Jacobo, Sally Paredes, Victoria Irigoin, Perla R. Colunga-Pedraza, David Gomez-Almaguer, Guillermo Ruiz-Argüelles, Fabiola Valvert, Melani Otañez, Arianna Robles Rodriguez, Carlos Best, Jose A Hernandez-Hernandez, Luis Enrique Malpica Castillo, Jorge J. Castillo, Luis Mario Villela Martinez
Journal: Blood (2024)
Pomalidomide, Rituximab, Orelabrutinib, and Minichop-like (PRO-miniCHOP) in Elderly Patients with Newly Diagnosed Diffuse Large-B Cell Lymphoma: Updated Results from a Phase II Study
Authors: Nana Ping, Changju Qu, Jiajie He, Hailing Liu, Rui Zou, Qian Zhu, Xiao Zhang, Depei Wu, Zhengming Jin
Journal: Blood (2024)
Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+ Leukemias
Authors: John Preston Claiborne, Daniel Li, B. Douglas Smith, Mark J. Levis, Ivana Gojo, Amy E. DeZern, Alexander J. Ambinder, Tania Jain, Gabrielle T. Prince, Lukasz P. Gondek, Theodoros Karantanos, Gabriel Ghiaur, William Brian Dalton, Jonathan Allen Webster
Journal: Blood (2024)
Collaborative Innovation: Tackling Health Disparities in Youth Living with Sickle Cell Disease through Co-Design
Authors: Keesha Roach, Betty S. Pace, Dora L Clayton-Jones, Janet Lucas, Joshua Field, Abir Bekhet, Ed Jenkins, Anne Costello, Joan Totka, Lee Za Ong, Kristin Haglund, Sylvia Pena
Journal: Blood (2024)
Combinatorial Therapy of CDK9 Inhibitor with CD19 CAR-T to Reciprocally Overcome Therapy Resistance and Enhance Treatment Efficacies Against Aggressive B-Cell Lymphomas
Authors: Qing Yin, Michelle Wang, Allen Hu, Jing Gao, Danielle C Llaneza, Loryn L Blackburn, Jeffrey W Craig, Bijal D Shah, Craig A. Portell, Michael E Williams, Jianguo Tao
Journal: Blood (2024)
Improved Genetic Characterization of Aggressive B-Cell Lymphoma at Diagnosis Using Next-Generation Sequencing
Authors: Mariana Bastos-Oreiro, Ismael De La Iglesia, Maria Chicano, Marina Gomez Llobell, Francisco Diaz Crespo, Paula Fernández Caldas-González, Juan Carlos Triviño, Raquel Fernandez, Ramon Garcia-Sanz, Ismael Buño, Carolina Martinez-Laperche
Journal: Blood (2024)
Clinical Utility of Ctdna Detection By NGS for Diagnosis of CNS Lymphoma
Authors: Ana Jiménez Ubieto, Alejandro Martín-Muñoz, Ricardo Errazquin, Yanira Ruiz-Heredia, Laura Rufián, Margarita Rodríguez, Esther Parra, Tycho Baumann, Antonia Rodriguez Izquierdo, Maria Teresa Cedena Romero, Joaquin Martínez-López, Rosa Ayala, Inmaculada Rapado
Journal: Blood (2024)
BEAT Chemofree Regimen for Relapsed/Refractory and De Novo T-ALL
Authors: Jieping Lin, Xuan Zhou, Zhixiang Wang, Dainan Lin, Yu Zhan, Zan Li, Jiwei Huang, Yonghua Li, Xudong Ma, Qifa Liu, Li Xuan, Yang Xu, Hongsheng Zhou
Journal: Blood (2024)
Identification of a Circulating Serum miRNA Signature As a Predictive Biomarker and Potential Therapeutic Target in Diffuse Large B-Cell Lymphoma
Authors: Giulia Regazzo, Giulia Vari, Francesco Marchesi, Andrea Sacconi, Francesca Palombi, Mariangela Novello, Elena Papa, Martina Tomassi, Francesco Pisani, Andrea Mengarelli, Maria Giulia Rizzo
Journal: Blood (2024)
Multiomic Single Cell Profiling Identifies Drivers of Progression in T-Cell Prolymphocytic Leukemia
Authors: Vishakha Anand Pawar, Arnau Peris Cuesta, Akanksha Aradhya, Claudia Kettlun, Swaminathan P Iyer, Sachet Shukla, Tapan M. Kadia, Francisco Vega, Deepa Sampath
Journal: Blood (2024)
Impact of Response to Bridging Therapy on Outcomes of CAR-T Therapy in Relapsed/Refractory DLBCL: A Single Center Retrospective Analysis
Authors: Nishanth Thalambedu, Brad Fugere, Sruthi Vellanki, Anup Kumar Trikannad, Mamatha Gaddam, Muthu V. Kumaran, Cesar Giancarlo Gentille Sanchez, Ankur Varma
Journal: Blood (2024)
Proteinuria with Preserved Renal Function: A Retrospective Cohort Study of Myeloma Patients with Significant Proteinuria without Acute Kidney Injury
Authors: Michael Sang Hughes, Metodi Balev, Jai Radhakrishnan, Divaya Bhutani, Markus Mapara, Andrew Eisenberger, Suzanne Lentzsch, Rajshekhar Chakraborty
Journal: Blood (2024)
35-Nucleotide Insertion between Exon 8 and Exon 9 Splicing Transcript, Clinical Significance in 20 Adult and Pediatric Chronic Myeloid Leukemia (CML) Ph+ Patients in Mexico City
Authors: Rafael Hurtado Monroy, Estefania Frances, Angelica S. Rios del rio, Norma López-Santiago, Janet Rojas Aguilar
Journal: Blood (2024)
Ixazomib Based Regimens As Front-Line Treatment in Newly Diagnosed Multiple Myeloma Patients in China: A Real-World Data from Infinite Study
Authors: Fu Cheng Cheng, Song Jin, Junling Zhuang, Xin Zhou, Fan Zhou, Yuhua Li, Kaiyang Ding, Ting Niu, Wenming Chen, Baijun Fang, Li-Li Chen, Rong Fu, Hao Zhang, Jiaping Fu, Xiuju Wang, Sha Liu, Lin Li, Depei Wu
Journal: Blood (2024)
Prognostic Impact of T(11;14) in Newly Diagnosed Patients with Multiple Myeloma in the Era of Modern Treatments
Authors: Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Panagiotis Malandrakis, Alexandros Briasoulis, Charalampos Filippatos, Despina Fotiou, Magdalini Migkou, Vasiliki Spiliopoulou, Foteini Theodorakakou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Maria Gavriatopoulou
Journal: Blood (2024)
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and <i> <i>KIT</i> </i> Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSⅢ-AML18 Trial
Authors: Yixin Hu, Xiuli Ju, Yunyan He, Ningling Wang, Xiaowen Zhai, Yufeng Liu, Hua Jiang, Hongjun Liu, Liangchun Yang, Minghua Yang, Jixia Luo, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu
Journal: Blood (2024)
Single-Center Validation of the Second Revised International Staging System (R2-ISS) in a Population of Transplant-Eligible (TE) Newly-Diagnosed Multiple Myeloma (NDMM) Treated with Bortezomib-Based Regimens
Authors: Isabel Mesquita, Joana Vieira, Helena Martins, Joao F. Lacerda, Graca Esteves
Journal: Blood (2024)
Impact of Self-Identified Race on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients Receiving Induction Therapy with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd)
Authors: Nisha S. Joseph, Shruti Gupta, Jonathan L. Kaufman, Sara Dicamillo, Danielle Roberts, Vikas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Sagar Lonial, Ajay K. Nooka
Journal: Blood (2024)
Clinical Significance of <i>HOX</i> and <i>Meis</i> gene Expression Profiling in Acute Myeloid Leukemia
Authors: Vikram Dhillon, Jeff Aguilar, Paul Kim, Dakshin Padmanabhan, Sandhya Dhiman, Gregory Dyson, Jaroslaw Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood (2024)
Trends and Disparities in Autoimmune Hemolytic Anemia-Related Mortality in the United States from 1999 to 2020: Insights from the CDC Wonder Database
Authors: Moazzam Shahzad, Eeman Ahmad, Shahzaib Ahmed, Umar Akram, Muhammad Bilal Sardar, Fatima Tuz Zahra, Qamar Iqbal, Muhammad Umair Mushtaq, Michael V. Jaglal
Journal: Blood (2024)
Economic Burden Associated with Switching to Second Line Asparaginase (Recombinant Erwinia) in Pediatrics, Adolescents and Young Adults (AYA) with Acute Lymphoblastic Leukemia (ALL)
Authors: Meghan McCormick, Tina Gu, Tarun Bhagnani, Indrani Chatterjee, Arun Prashar, Ravi Potluri, Eros Papademetriou, Luke Maese
Journal: Blood (2024)
Improving Quality Outcomes through a Medicine Hospitalist-Driven Malignant Hematology Service
Authors: Grace Lee, Steven Benyahia, Misbahuddin Syed, Hardik Thakkar, Richard R Reich, James Lochner, Leidy Lismeris Isenalumhe, Timothy Hembree, Enas Abdallah, Neha Verma
Journal: Blood (2024)
Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)
Authors: Li Gao, Hua Jiang, Xiuli Ju, Yunyan He, Hongjun Liu, Xiaowen Zhai, Ningling Wang, Minghua Yang, Jixia Luo, Yufeng Liu, Liangchun Yang, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu
Journal: Blood (2024)
Demographic Characteristics and Mortality Trends in Jehovah's Witnesses Patients with Chemotherapy-Induced Anemia Treated with Erythropoietin-Stimulating Agents: Analysis of the National Inpatient Sample (NIS) Database
Authors: Mrunanjali Gaddam, Samridhi Sinha, Sujana Sanka, Rabia Iqbal, Swathi Kavuri, Jayalekshmi Jayakumar, Ana Colon Ramos, Surbhi Singh, Sobha Atluri, Michelle Koifman, Asmat Ullah
Journal: Blood (2024)
Prediction of Volasertib Sensitivity in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Azacitidine
Authors: Lokesh Patil, Christine J. Gu, Cristina Tognon, Nicola Long, Kara Johnson, Melissa A Fischer, Somedeb Ball, Michael R. Savona, Chris Leonardi, Joseph Wagner, Glenn Michelson, Markus D. Lacher
Journal: Blood (2024)
Targeted Treatment Additions Ibrutinib + Bortezomib + R-CHOP for Higher-Risk DLBCL: Efficacy, Feasibility and Molecular Signatures for Future Treatment Decisions
Authors: Sophy Denker, Aitomi Bittner, Julia Kase, Mareike Frick, Jörg Hoffmann, Corinna Trenker, Ulrich Keller, Christian Bogner, Andreas Hüttmann, Jan Dürig, Martin Janz, Stephan Mathas, Reinhard Marks, Ulrike Krohn, Il-Kang Na, Paulina Richter-Pechanska, Animesh Bhattacharya, Bernhard Gebauer, Lynn Savic, Norbert Hübner, Altuna Akalin, Roland Eils, Lars Bullinger, Clemens Schmitt
Journal: Blood (2024)
The Association between Serum Ferritin and Survival Outcome in AML Patients: A Meta-Analysis
Authors: Manasawee Tanariyakul, Chalothorn Wannaphut, Panisara Fangsaard, Chanakarn Kanitthamniyom, Phuuwadith Wattanachayakul, Sakditad Saowapa
Journal: Blood (2024)
Targeting the Proteasomal 19S Regulatory Complex Instead of the 20S Catalytic Complex As a Novel Therapeutic Strategy in FLT3+ AML
Authors: Andres J Rubio, Mayra A. Gonzalez, Idaly M. Olivas, David Elliott, Mariah Black, Desiree N. Tapia, Andrea Orozco, Sharon Siby, Connor Jordan, Mehrshad Kevian, Alfredo Dominguez, Boronai Tychhon, Jesse C Allen, Anna M. Eiring
Journal: Blood (2024)
Real World Analysis of the Efficacy, Prognosis and Safety of Daratumumab, Carfilzomib, and Dexamethasone (DKD) in Relapsed or Refractory Multiple Myeloma Patients
Authors: Chengcheng Fu, Hongying You, Song Jin, Panfeng Wang, Lingzhi Yan, Liying Zhang, Tingting Lu, Xiao Gao, Lei Jiang, Hongchun Qiu, Jingjing Shang, Yingying Zhai, Weiqin Yao, Shuang Yan, Zhi Yan, Depei Wu
Journal: Blood (2024)
Evolving Burden of Multiple Myeloma and Its Trend in European Union Countries from 1990-2021: A Secondary Analysis from the Global Burden of Disease Study 2021
Authors: Shivani Modi, Saifullah Syed, Ashwinikumar Shandilya, Divya Durga, Ratan PAL Yadav, Mohit Lakkimsetti, Vishrant Amin, Juhi Patel, Hardik Jain, Hardik Dineshbhai Desai, Keethanshan Markandu, Adit Alpesh Dharia
Journal: Blood (2024)
Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies
Authors: Megan Broughton, Subodh Bhatta, Nidhi Sharma, Elvira Umyarova, Abdullah Mohammad Khan, Srinivas Devarakonda, Naresh Bumma, Ashley Rosko, Don Benson, Francesca Cottini
Journal: Blood (2024)
Development of an Agent-Based Model to Investigate Response Durability in Hemophilia B Patients Treated with the AAV-Based Coagulation Factor IX (FIX) Gene Therapy Etranacogene Dezaparvovec
Authors: Yuezhe Li, Partha Nandy, Eric Jordie, Karsten Peppel, Timothy Knab, Daniel Kirouac, A. Katharina Wilkins, Silpa Nuthalapati
Journal: Blood (2024)
Utilization of Multiple Myeloma Treatments in Developing Countries: Systematic Review and Meta-Analysis
Authors: Jehad Almasri, Bashar Hasan, Zin Tarakji, Faris W. Naffa', Lynn Warner, Hira Mian, Rajshekhar Chakraborty, Ghulam Rehman Mohyuddin, Samer Al Hadidi
Journal: Blood (2024)
Treatment Patterns of Immunoglobulin Replacement Therapy Among Patients with Multiple Myeloma in the United States: A Real-World Analysis
Authors: Fidelia Ida, Bharat Ramakrishna, Kaz Nasserinejad, Adriana Radu, John-Philip Lawo, Xiang Zhang, David Gardiner, Lara Yoon, John Shen, Elizabeth C. Dabrowski, Saarah Khan, Gabriela Espinoza, Zainab Shahid, Sergio A. Giralt
Journal: Blood (2024)
Defining the Rates of Cytokine Release Syndrome Associated with Talquetamab Step-up Doses
Authors: Issam S. Hamadeh, Tala Shekarkhand, Colin Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin Hultcrantz, Alexander M. Lesokhin, Sham Mailankody, Hani Hassoun, Urvi A. Shah, Kylee H Maclachlan, Sridevi Rajeeve, Hamza Hashmi, Gunjan L. Shah, Michael Scordo, David J. Chung, Heather J. Landau, Sergio A. Giralt, Saad Z. Usmani, Carlyn Rose Tan
Journal: Blood (2024)